首页> 美国卫生研究院文献>Particle and Fibre Toxicology >Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the relative deposition index: Evidence for clearance through microvasculature
【2h】

Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the relative deposition index: Evidence for clearance through microvasculature

机译:使用相对沉积指数重新评估肺部二氧化钛纳米颗粒分布:通过微脉管系统清除的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTranslocation of nanoparticles (NP) from the pulmonary airways into other pulmonary compartments or the systemic circulation is controversially discussed in the literature. In a previous study it was shown that titanium dioxide (TiO2) NP were "distributed in four lung compartments (air-filled spaces, epithelium/endothelium, connective tissue, capillary lumen) in correlation with compartment size". It was concluded that particles can move freely between these tissue compartments. To analyze whether the distribution of TiO2 NP in the lungs is really random or shows a preferential targeting we applied a newly developed method for comparing NP distributions.
机译:背景技术在文献中有争议地讨论了纳米颗粒(NP)从肺气道到其他肺室或体循环的转运。在先前的研究中表明,二氧化钛(TiO2)NP“与四个肺隔室(充满空气的空间,上皮/内皮,结缔组织,毛细管腔)分布在与隔室大小相关的位置”。结论是颗粒可以在这些组织隔室之间自由移动。为了分析TiO2 NP在肺中的分布是否确实是随机的或显示出优先靶向性,我们应用了一种新开发的方法来比较NP分布。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号